【Cheng Yeh Medical】Company announces that its important subsidiary, Xing Ye Biotechnology Co., Ltd., has signed a syndicated loan agreement with a banking consortium

1. Date of occurrence of the event: 115/05/08 2. Counterparty to the contract or commitment: First Commercial Bank, Taipei Fubon Commercial Bank, and other 6 syndicated loan banking consortiums. 3. Relationship with the company: None 4. Start and end dates of the contract or commitment (or termination date): 7 years from the first drawdown date. 5. Main content (not applicable to termination): Syndicated loan agreement for NT$5.3 billion. 6. Restrictive clauses (not applicable to termination): Handled in accordance with the syndicated loan agreement. 7. Commitments (not applicable to termination): Handled in accordance with the syndicated loan agreement. 8. Other important agreed matters (not applicable to termination): Handled in accordance with the syndicated loan agreement. 9. Impact on the company's finance and business: Replenishment of working capital 10. Specific purpose: Replenishment of working capital 11. Other matters that need to be specified (If the subject of the event or resolution is a public company or above, this material information also meets the requirements of Article 7, Paragraph 8 of the Enforcement Rules of the Securities and Exchange Act regarding matters that have a significant impact on shareholders' equity or securities prices): None Keyword: Material Information